Harvard Bioscience Inc 's ability to collect accounts receivable sequentially worsen to 6.02, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Harvard Bioscience Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 61 days, from 59 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 285 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 650 to 2147.

What is Receivable Turnover Ratio?
What is Harvard Bioscience Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HBIO Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	23.15 %	21.47 %	8.11 %	7.92 %	-5.63 %
Y / Y Revenue Change	10.86 %	16.35 %	-4.44 %	-3.23 %	-8.01 %
Receivable Turnover Ratio (TTM)	6.02	6.16	6.22	6.42	6.62
HBIO's Total Ranking	# 2147	# 650	# 1886	# 1930	#
Accounts Receivable average collection period days	61	59	59	57	55
Seq. Receivable Change	2.84 %	-0.49 %	-9.17 %	32.49 %	1.44 %
Seq. Revenue Change	-2.34 %	12.27 %	-19.58 %	25.73 %	2.5 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 9
Healthcare Sector	# 286
Overall Market	# 2147

Receivable Turnover Ratio Statistics
High	Average	Low
7.75	6.61	5.15
(Dec 31 2012)		(Dec 31 2017)

HBIO Company Profile • Back to HBIO Efficiency Comparisons • Compare HBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Harvard Bioscience Inc 's Accounts Receivable	$ 15 Millions	Visit HBIO's Balance sheet
Harvard Bioscience Inc 's Sales TTM	$ 90 Millions	Visit HBIO's Income Statement
Sources of HBIO's Revenues		Visit HBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HBIO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HBIO's Growth Rates	HBIO's Roa	HBIO's Inventory Turnover Ratio	HBIO's Dividend Comparisons
HBIO's Profitability Ratios	HBIO's Roi	HBIO's Asset Turnover Ratio	HBIO's Dividend Growth
HBIO's Valuation Ratios	HBIO's Roe	HBIO's Financial Strength Ratios	HBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Longeveron Inc	15.48	$ 1.165 Millions	$ 0.075 Millions
Biogen Inc	15.19	$ 10,297.300 Millions	$ 677.900 Millions
Lifestance Health Group Inc	14.89	$ 1,676.889 Millions	$ 112.631 Millions
Amneal Pharmaceuticals Inc	14.24	$ 3,196.184 Millions	$ 224.488 Millions
Lifemd Inc	13.58	$ 148.224 Millions	$ 10.917 Millions
Corcept Therapeutics Inc	13.44	$ 963.647 Millions	$ 71.710 Millions
Precipio inc	13.38	$ 27.762 Millions	$ 2.075 Millions
Volitionrx Limited	13.38	$ 3.445 Millions	$ 0.258 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Biodesix Inc	11.45	$ 105.212 Millions	$ 9.192 Millions
Gossamer Bio Inc	11.37	$ 78.423 Millions	$ 6.896 Millions
Lineage Cell Therapeutics Inc	11.35	$ 10.836 Millions	$ 0.955 Millions
Qhslab Inc	11.33	$ 2.957 Millions	$ 0.261 Millions
Icu Medical Inc	11.32	$ 2,183.556 Millions	$ 192.845 Millions
Mannkind Corporation	10.97	$ 413.370 Millions	$ 37.686 Millions
Seastar Medical Holding Corp	10.80	$ 2.165 Millions	$ 0.200 Millions
Lensar Inc	10.64	$ 60.079 Millions	$ 5.645 Millions
Immucell Corporation	10.48	$ 32.454 Millions	$ 3.096 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Voyager Therapeutics Inc	9.84	$ 25.108 Millions	$ 2.551 Millions
Myomo Inc	9.66	$ 47.775 Millions	$ 4.947 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Sunshine Biopharma Inc	9.19	$ 35.372 Millions	$ 3.850 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Co diagnostics Inc	9.12	$ 0.859 Millions	$ 0.094 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions

Date modified: 2026-11-11T13:45:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.